BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 9570999)

  • 1. Application of tumor markers in ovarian malignancies.
    Malati T; Kumari GR; Yadagiri B
    Indian J Clin Biochem; 2001 Jul; 16(2):224-33. PubMed ID: 23105325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of complex pelvic masses using a multivariate index assay: a decision analysis.
    Kim KH; Zsebik GN; Straughn JM; Landen CN
    Gynecol Oncol; 2012 Sep; 126(3):364-8. PubMed ID: 22659191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a novel ELISA for the tumor-associated antigen CA 72-4 in patients with ovarian cancer.
    Buderath P; Kasimir-Bauer S; Aktas B; Rasch J; Kimmig R; Zeller T; Heubner M
    Future Sci OA; 2016 Dec; 2(4):FSO145. PubMed ID: 28116127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ovarian tumors in postmenopausal women: report of 100 cases and review of the literature].
    Kehila M; Kebaili S; Hidar S; Boughizane S
    Pan Afr Med J; 2014; 19():235. PubMed ID: 25838863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial.
    Partridge EE; Greenlee RT; Riley TL; Commins J; Ragard L; Xu JL; Buys SS; Prorok PC; Fouad MN
    Obstet Gynecol; 2013 Jan; 121(1):25-31. PubMed ID: 23262924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of a suspicious adnexal mass: a clinical practice guideline.
    Dodge JE; Covens AL; Lacchetti C; Elit LM; Le T; Devries-Aboud M; Fung-Kee-Fung M;
    Curr Oncol; 2012 Aug; 19(4):e244-57. PubMed ID: 22876153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review.
    Medeiros LR; Rosa DD; da Rosa MI; Bozzetti MC
    Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):99-105. PubMed ID: 18995946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of diagnostic indices comprising clinical, sonographic, and biomarker data for discriminating benign from malignant ovarian masses.
    Stukan M; Dudziak M; Ratajczak K; Grabowski JP
    J Ultrasound Med; 2015 Feb; 34(2):207-17. PubMed ID: 25614393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter study.
    Schutter EM; Kenemans P; Sohn C; Kristen P; Crombach G; Westermann R; Môbus V; Kaufmann M; Caffier H; Schmidt-Rhode P
    Cancer; 1994 Aug; 74(4):1398-406. PubMed ID: 8055463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective multicenter study on CA 125 in postmenopausal pelvic masses.
    Maggino T; Gadducci A; D'Addario V; Pecorelli S; Lissoni A; Stella M; Romagnolo C; Federghini M; Zucca S; Trio D
    Gynecol Oncol; 1994 Aug; 54(2):117-23. PubMed ID: 8063233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass.
    Schutter EM; Davelaar EM; van Kamp GJ; Verstraeten RA; Kenemans P; Verheijen RH
    Am J Obstet Gynecol; 2002 Aug; 187(2):385-92. PubMed ID: 12193930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis?
    Valentin L; Ameye L; Jurkovic D; Metzger U; Lécuru F; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2006 Apr; 27(4):438-44. PubMed ID: 16526098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study.
    Schutter EM; Sohn C; Kristen P; Möbus V; Crombach G; Kaufmann M; Caffier H; Kreienberg R; Verstraeten AA; Kenemans P
    Gynecol Oncol; 1998 Apr; 69(1):56-63. PubMed ID: 9570999
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.